Unknown

Dataset Information

0

Special report of the RSNA COVID-19 task force: systematic review of outcomes associated with COVID-19 neuroimaging findings in hospitalized patients.


ABSTRACT:

Objective

We reviewed the literature to describe outcomes associated with abnormal neuroimaging findings among adult COVID-19 patients.

Methods

We performed a systematic literature review using PubMed and Embase databases. We included all studies reporting abnormal neuroimaging findings among hospitalized patients with confirmed COVID-19 and outcomes. Data elements including patient demographics, neuroimaging findings, acuity of neurological symptoms and/or imaging findings relative to COVID-19 onset (acute, subacute, chronic), and patient outcomes were recorded and summarized.

Results

After review of 775 unique articles, a total of 39 studies comprising 884 COVID-19 patients ≥ 18 years of age with abnormal neuroimaging findings and reported outcomes were included in our analysis. Ischemic stroke was the most common neuroimaging finding reported (49.3%, 436/884) among patients with mortality outcomes data. Patients with intracranial hemorrhage (ICH) had the highest all-cause mortality (49.7%, 71/143), followed by patients with imaging features consistent with leukoencephalopathy (38.5%, 5/13), and ischemic stroke (30%, 131/436). There was no mortality reported among COVID-19 patients with acute disseminated encephalomyelitis without necrosis (0%, 0/8) and leptomeningeal enhancement alone (0%, 0/12). Stroke was a common acute or subacute neuroimaging finding, while leukoencephalopathy was a common chronic finding.

Conclusion

Among hospitalized COVID-19 patients with abnormal neuroimaging findings, those with ICH had the highest all-cause mortality; however, high mortality rates were also seen among COVID-19 patients with ischemic stroke in the acute/subacute period and leukoencephalopathy in the chronic period.

Advances in knowledge

Specific abnormal neuroimaging findings may portend differential mortality outcomes, providing a potential prognostic marker for hospitalized COVID-19 patients.

SUBMITTER: Mogensen MA 

PROVIDER: S-EPMC8553187 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8639392 | biostudies-literature
| S-EPMC9744033 | biostudies-literature
| S-EPMC9764840 | biostudies-literature
| S-EPMC7658900 | biostudies-literature
| S-EPMC8420082 | biostudies-literature
| S-BSST1269 | biostudies-other
| S-EPMC8014702 | biostudies-literature
| S-EPMC7993245 | biostudies-literature
2023-01-27 | GSE195898 | GEO
2021-07-24 | GSE180743 | GEO